vs
Liberty Broadband Corp（LBRDA）与Pediatrix Medical Group, Inc.（MD）财务数据对比。点击上方公司名可切换其他公司
Pediatrix Medical Group, Inc.的季度营收约是Liberty Broadband Corp的1.9倍（$493.8M vs $261.0M），Liberty Broadband Corp净利率更高（146.7% vs 6.8%，领先139.9%），Liberty Broadband Corp同比增速更快（6.1% vs -1.7%），过去两年Liberty Broadband Corp的营收复合增速更高（4.3% vs -0.1%）
本公司是一家覆盖英、荷、美三地的跨国电信企业，注册地为百慕大，在伦敦、阿姆斯特丹、丹佛设有总部，旗下拥有多家对应司法辖区的运营主体，其中英国主体为公开上市实体，2005年由自由媒体国际业务板块与UnitedGlobalCom合并成立。
Pediatrix Medical Group是美国领先的专科医疗服务提供商，核心业务覆盖母胎医学、新生儿科、儿科心脏病学等儿科亚专科领域，与美国各地医疗机构合作，为女性、新生儿及儿童提供循证专科医疗服务。
LBRDA vs MD — 直观对比
营收规模更大
MD
是对方的1.9倍
$261.0M
营收增速更快
LBRDA
高出7.8%
-1.7%
净利率更高
LBRDA
高出139.9%
6.8%
两年增速更快
LBRDA
近两年复合增速
-0.1%
损益表 — Q2 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $261.0M | $493.8M |
| 净利润 | $383.0M | $33.7M |
| 毛利率 | — | — |
| 营业利润率 | 15.7% | 9.9% |
| 净利率 | 146.7% | 6.8% |
| 营收同比 | 6.1% | -1.7% |
| 净利润同比 | 96.4% | 10.5% |
| 每股收益（稀释后） | $2.68 | $0.40 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LBRDAMD
| Q4 25 | — | $493.8M | ||
| Q3 25 | — | $492.9M | ||
| Q2 25 | $261.0M | $468.8M | ||
| Q1 25 | $266.0M | $458.4M | ||
| Q4 24 | $263.0M | $502.4M | ||
| Q3 24 | $262.0M | $511.2M | ||
| Q2 24 | $246.0M | $504.3M | ||
| Q1 24 | $245.0M | $495.1M |
净利润LBRDAMD
| Q4 25 | — | $33.7M | ||
| Q3 25 | — | $71.7M | ||
| Q2 25 | $383.0M | $39.3M | ||
| Q1 25 | $268.0M | $20.7M | ||
| Q4 24 | $291.0M | $30.5M | ||
| Q3 24 | $142.0M | $19.4M | ||
| Q2 24 | $195.0M | $-153.0M | ||
| Q1 24 | $241.0M | $4.0M |
营业利润率LBRDAMD
| Q4 25 | — | 9.9% | ||
| Q3 25 | — | 13.8% | ||
| Q2 25 | 15.7% | 12.8% | ||
| Q1 25 | 16.2% | 7.0% | ||
| Q4 24 | 4.9% | 7.8% | ||
| Q3 24 | 11.5% | 6.6% | ||
| Q2 24 | 8.5% | -31.3% | ||
| Q1 24 | 11.4% | 3.2% |
净利率LBRDAMD
| Q4 25 | — | 6.8% | ||
| Q3 25 | — | 14.5% | ||
| Q2 25 | 146.7% | 8.4% | ||
| Q1 25 | 100.8% | 4.5% | ||
| Q4 24 | 110.6% | 6.1% | ||
| Q3 24 | 54.2% | 3.8% | ||
| Q2 24 | 79.3% | -30.3% | ||
| Q1 24 | 98.4% | 0.8% |
每股收益（稀释后）LBRDAMD
| Q4 25 | — | $0.40 | ||
| Q3 25 | — | $0.84 | ||
| Q2 25 | $2.68 | $0.46 | ||
| Q1 25 | $1.87 | $0.24 | ||
| Q4 24 | $2.04 | $0.37 | ||
| Q3 24 | $0.99 | $0.23 | ||
| Q2 24 | $1.36 | $-1.84 | ||
| Q1 24 | $1.69 | $0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $180.0M | $375.2M |
| 总债务越低越好 | $3.1B | $570.5M |
| 股东权益账面价值 | $10.4B | $865.9M |
| 总资产 | $16.6B | $2.2B |
| 负债/权益比越低杠杆越低 | 0.30× | 0.66× |
8季度趋势，按日历期对齐
现金及短期投资LBRDAMD
| Q4 25 | — | $375.2M | ||
| Q3 25 | — | $340.1M | ||
| Q2 25 | $180.0M | $224.7M | ||
| Q1 25 | $226.0M | $99.0M | ||
| Q4 24 | $163.0M | $229.9M | ||
| Q3 24 | $168.0M | $103.8M | ||
| Q2 24 | $73.0M | $19.4M | ||
| Q1 24 | $108.0M | $8.0M |
总债务LBRDAMD
| Q4 25 | — | $570.5M | ||
| Q3 25 | — | $577.2M | ||
| Q2 25 | $3.1B | $583.9M | ||
| Q1 25 | $3.8B | $590.5M | ||
| Q4 24 | $3.8B | $597.1M | ||
| Q3 24 | $3.7B | — | ||
| Q2 24 | $3.6B | — | ||
| Q1 24 | $3.6B | — |
股东权益LBRDAMD
| Q4 25 | — | $865.9M | ||
| Q3 25 | — | $890.7M | ||
| Q2 25 | $10.4B | $833.8M | ||
| Q1 25 | $10.1B | $789.2M | ||
| Q4 24 | $9.8B | $764.9M | ||
| Q3 24 | $9.5B | $732.5M | ||
| Q2 24 | $9.3B | $706.5M | ||
| Q1 24 | $9.1B | $856.2M |
总资产LBRDAMD
| Q4 25 | — | $2.2B | ||
| Q3 25 | — | $2.2B | ||
| Q2 25 | $16.6B | $2.1B | ||
| Q1 25 | $17.0B | $2.0B | ||
| Q4 24 | $16.7B | $2.2B | ||
| Q3 24 | $16.3B | $2.1B | ||
| Q2 24 | $16.0B | $2.0B | ||
| Q1 24 | $15.7B | $2.2B |
负债/权益比LBRDAMD
| Q4 25 | — | 0.66× | ||
| Q3 25 | — | 0.65× | ||
| Q2 25 | 0.30× | 0.70× | ||
| Q1 25 | 0.38× | 0.75× | ||
| Q4 24 | 0.38× | 0.78× | ||
| Q3 24 | 0.39× | — | ||
| Q2 24 | 0.39× | — | ||
| Q1 24 | 0.40× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $91.0M | $114.1M |
| 自由现金流经营现金流 - 资本支出 | $37.0M | — |
| 自由现金流率自由现金流/营收 | 14.2% | — |
| 资本支出强度资本支出/营收 | 20.7% | — |
| 现金转化率经营现金流/净利润 | 0.24× | 3.39× |
| 过去12个月自由现金流最近4个季度 | $-49.0M | — |
8季度趋势，按日历期对齐
经营现金流LBRDAMD
| Q4 25 | — | $114.1M | ||
| Q3 25 | — | $137.3M | ||
| Q2 25 | $91.0M | $137.2M | ||
| Q1 25 | $78.0M | $-117.5M | ||
| Q4 24 | $1.0M | $133.0M | ||
| Q3 24 | $24.0M | $91.8M | ||
| Q2 24 | $27.0M | $107.0M | ||
| Q1 24 | $52.0M | $-125.2M |
自由现金流LBRDAMD
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $37.0M | — | ||
| Q1 25 | $13.0M | — | ||
| Q4 24 | $-63.0M | — | ||
| Q3 24 | $-36.0M | — | ||
| Q2 24 | $-35.0M | — | ||
| Q1 24 | $-9.0M | — |
自由现金流率LBRDAMD
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 14.2% | — | ||
| Q1 25 | 4.9% | — | ||
| Q4 24 | -24.0% | — | ||
| Q3 24 | -13.7% | — | ||
| Q2 24 | -14.2% | — | ||
| Q1 24 | -3.7% | — |
资本支出强度LBRDAMD
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 20.7% | — | ||
| Q1 25 | 24.4% | — | ||
| Q4 24 | 24.3% | — | ||
| Q3 24 | 22.9% | — | ||
| Q2 24 | 25.2% | — | ||
| Q1 24 | 24.9% | — |
现金转化率LBRDAMD
| Q4 25 | — | 3.39× | ||
| Q3 25 | — | 1.91× | ||
| Q2 25 | 0.24× | 3.49× | ||
| Q1 25 | 0.29× | -5.66× | ||
| Q4 24 | 0.00× | 4.36× | ||
| Q3 24 | 0.17× | 4.72× | ||
| Q2 24 | 0.14× | — | ||
| Q1 24 | 0.22× | -31.03× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LBRDA
暂无分部数据
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
